Tumor antigens are abnormal proteins produced by cancer cells that can be used for testing, diagnosis, and potentially for targeted cancer treatment and vaccine development. The immune system recognizes them as abnormal and can attack them, making them a valuable tool for cancer research.
Tumor antigens are abnormal proteins produced by cancer cells. The host’s body reacts to these antigens, recognizing them as abnormal. There are a number of potential applications for tumor antigens, ranging from testing for certain antigens to learning more about a tumor to developing vaccines for certain types of cancer. A number of cancer researchers study these antigens to learn more about how they are formed and function.
In a healthy human body, the immune system has learned to ignore proteins normally found in the body and attack proteins that appear to be foreign in nature. In the case of tumor antigens, normal cells mutate and start growing out of control, and the mutation can lead to the development of abnormal proteins that can be seen and attacked by the immune system. While the immune system can’t necessarily eliminate all abnormal cells, it can cause inflammation and associated problems around the site of the tumor growth.
Some antigens are tumor specific, associated only with tumor growths. Others are tumor-associated, which means they can occur in tumors or in normal cells. Using known antigens, a doctor can test tumor growths to learn more about them and where they originated from by looking for particular antigens of interest. Researchers are also studying tumors with the goal of identifying new antigens that can be used in testing and diagnosis.
One potential application for tumor antigens is in the treatment of cancer. Using tumor-specific antigens, a treatment could be developed to target those antigens, allowing a doctor to deliver a dose of drug directly to the tumor without harming other parts of the body. Since many cancer treatments are highly destructive and indiscriminate, a targeted drug could make a huge difference in cancer treatment by being more effective and less harmful to the patient, reducing the drug’s side effects.
Tumor antigens could also potentially be used in the development of vaccines for specific types of cancer. Vaccines work by exposing the body to a controlled dose of an antigen, allowing the immune system to develop antibodies that will attack that antigen if it is detected in the future. Tumor antigens could be used in the same way, teaching the body to attack and kill cancerous cells if it identifies them. Because cancers are so variable, it wouldn’t be possible to create a single vaccine to protect against all cancers, but specific common cancers could be targeted with various vaccines.
Protect your devices with Threat Protection by NordVPN
